Valeant Pharmaceuticals International Inc(NYSE : VRX)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Loading VRX News...
Health Technology » Pharmaceuticals Other
|VRX||Valeant Pharmaceuticals International, Inc.||-1.06%||10.75||9.9%||$297.33m|
|PRGO||Perrigo Co. Plc||-0.29%||67.96||4.8%||$179.65m|
|SHPG||Shire PLC Sponsored ADR||0.70%||175.23||0.3%||$161.46m|
|ENDP||Endo International Plc||-0.20%||9.97||8.9%||$131.03m|
|JAZZ||Jazz Pharmaceuticals Plc||0.45%||143.14||1.9%||$89.29m|
|UTHR||United Therapeutics Corporation||0.66%||140.05||11.5%||$85.74m|
|PRXL||PAREXEL International Corporation||0.86%||62.35||6.7%||$70.21m|
|PCRX||Pacira Pharmaceuticals, Inc.||-0.11%||46.90||16.9%||$67.17m|
|PTLA||Portola Pharmaceuticals, Inc.||0.55%||38.44||10.3%||$48.48m|
|ICPT||Intercept Pharmaceuticals, Inc.||0.80%||116.73||22.8%||$45.29m|
|HZNP||Horizon Pharma plc||-1.31%||14.37||9.7%||$45.07m|
|GWPH||GW Pharmaceuticals PLC Sponsored ADR||0.04%||121.17||9.9%||$39.39m|
Valeant Pharmaceuticals International, Inc. is a pharmaceutical company which engages in developing, manufacturing, and marketing pharmaceutical products in the areas of dermatology, eye health, neurology, and generics. It operates through the Developed Markets and Emerging Markets. The Developed Markets segment offers over-the-counter and medical products as well as alliance and contract service revenues, in the areas of dermatology and podiatry, neurology, gastrointestinal disorders, eye health, oncology and urology, dentistry, aesthetics, and women's health. The Emerging Markets consists of branded generic pharmaceutical and branded pharmaceuticals; over-the-counter and medical device products. The company was founded on March 29, 1994 and is headquartered in Laval, Canada.